Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry

Background and aim: Transarterial chemoembolization with drug-eluting microspheres (DEM-TACE) is recommended for patients with BCLC stage B hepatocellular carcinoma (HCC) and stage 0-A unsuitable for curative treatments. We assessed efficacy and safety along with hepatobiliary toxicities (HBT) of DE...

Full description

Bibliographic Details
Main Authors: Thierry de Baere, Boris Guiu, Maxime Ronot, Patrick Chevallier, Géraldine Sergent, Illario Tancredi, Lambros Tselikas, Marco Dioguardi Burgio, Lucas Raynaud, Frederic Deschamps, Gontran Verset
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
hepatocellular carcinoma
DEM-TACE
doxorubicin
idarubicin
hepatobiliary toxicities
Online Access:https://www.mdpi.com/2072-6694/12/11/3405

Internet

https://www.mdpi.com/2072-6694/12/11/3405

Similar Items